Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > Schwab

<< Previous

Bullboard Posts

Next >>

Comment by Bucknelly21on Jun 14, 2021 10:53am

187 Views

Post# 33381411

RE:RE:Schwab

SPCEO1 wrote: Actually, volume today is pretty strong, so that must have been a temporary abererration.

On the issue of LSA, it will be interesting to see what happens this week. Will LSA issue a report this week prior to the KOL webinar or will they wait until after the call? If TH is going to announce important new info at the webinar, my guess is they wait until after. If not, maybe they put one out this week in anticipation. Of course, we don't know if TH has paid LSA enough to get them to generate a report, so maybe it will just be the KOL webinar. We will know soon enough.

I am not sure how LSA actually does their job. I recieve lots of e-mail invitations to KOL events and with research reprots attached from them but have never been contacted by phone or even by a direct e-mail attempt to engage with me. Now my little firm may not be their target market either, so that may account for the lack of engagement.

So, I am not sure how effective LSA are in getting eyeballs to look at TH or any other stock but they do have a sizable staff which indicates a level of success in accomplishing this task. We will know soon enough if they will have a positive impact on TH's stock price.

Bucknelly21 wrote: Bid size 3.55 for 1 freaking share and ask is 3.59 for 13....